donepezil has been researched along with Myoclonic Jerk in 3 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An 80-year-old Greek woman with Alzheimer disease was admitted to the hospital with a sudden onset of myoclonus in both upper and lower extremities after receiving 30 mg of donepezil daily for 25 days." | 7.80 | Donepezil-induced myoclonus in a patient with Alzheimer disease. ( Anagnostou, E; Bougea, A; Gerakoulis, S; Kapaki, E; Kararizou, E; Paraskevas, G, 2014) |
| "An 80-year-old Greek woman with Alzheimer disease was admitted to the hospital with a sudden onset of myoclonus in both upper and lower extremities after receiving 30 mg of donepezil daily for 25 days." | 3.80 | Donepezil-induced myoclonus in a patient with Alzheimer disease. ( Anagnostou, E; Bougea, A; Gerakoulis, S; Kapaki, E; Kararizou, E; Paraskevas, G, 2014) |
| "Donepezil is a commonly prescribed cholinesterase inhibitor in Alzheimer's dementia." | 1.48 | Acute inability to mobilise resulting from probable donepezil-induced myoclonus. ( Henderson, EJ; Huffman, AJ; Whateley, JM, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Whateley, JM | 1 |
| Huffman, AJ | 1 |
| Henderson, EJ | 1 |
| Bougea, A | 1 |
| Gerakoulis, S | 1 |
| Anagnostou, E | 1 |
| Paraskevas, G | 1 |
| Kapaki, E | 1 |
| Kararizou, E | 1 |
| Papageorgiou, SG | 1 |
| Kontaxis, T | 1 |
| Antelli, A | 1 |
| Kalfakis, N | 1 |
3 other studies available for donepezil and Myoclonic Jerk
| Article | Year |
|---|---|
Acute inability to mobilise resulting from probable donepezil-induced myoclonus.
Topics: Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; Mobility | 2018 |
Donepezil-induced myoclonus in a patient with Alzheimer disease.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Myoclonus; Pi | 2014 |
Exacerbation of myoclonus by memantine in a patient with Alzheimer disease.
Topics: Aged; Alzheimer Disease; Donepezil; Excitatory Amino Acid Antagonists; Female; Humans; Indans; Meman | 2007 |